Lena G, Ternier J, Paz-Paredes A, Scavarda D
Unité fonctionnelle de neurochirurgie pédiatrique, hôpital des enfants de La Timone, 286 rue Saint-Pierre, 13385 Marseille cedex 05, France.
Neurochirurgie. 2007 Jun;53(2-3 Pt 2):223-37. doi: 10.1016/j.neuchi.2007.02.011.
Cavernomas represent 1.7 to 18% of all vascular malformations in children and 25% are observed in children under 18 years of age. Cases observed in neonates and infants have been published, but the mean age varies from 9.1 to 10.2 years. There is no predominance between boys and girls.
In children, hemorrhage is a common manifestation with an incidence varying from 27.3 to 78% versus 8 to 37% in adult patients. Isolated headaches occur in 2.8% of patients and elevated ICP is observed in 20.1%. Epilepsy is reported in 16 to 60% of children, depending on the series. Neurological deficits are observed in 22.7% of patients and are more severe for deep-seated and brainstem cavernoma. About 14.2% of the cases are discovered fortuitously in asymptomatic patients. Spinal cord deficits are observed in 5% of the cases.
Using data in the literature plus our personal series of 57 cases, 79.4% of lesions are in the supratentorial compartment and 20.6% in the posterior fossa, the majority located in the brainstem, most of them in the pons. Spinal cord cavernomas represent 5% and multiples cavernomas (12.6%) of the reviewed cases.
Appropriate management of cavernomas has long been a subject of much debate. Today, a consensus has been reached to favor medical management of asymptomatic and non hemorrhagic lesions and surgical management of symptomatic and/or hemorrhagic cavernomas whatever the localization. Progress in neuroimaging, surgical mapping, intraoperative monitoring and microsurgical techniques has greatly contributed to improved approach to those lesions.
Results obtained in 217 cases were reviewed. Near 70% of the children are neurologically intact, 19.3% are improved or stable, 2.7% worsened and 1.13% died. Results for epilepsy are very encouraging, surgery is efficient in almost all the children except for temporal lobe cavernomas where invasive presurgical evaluation is recommended. Deep-seated and brainstem cavernomas can safely be removed in most of the cases. Only two children died from recurrent hemorrhage due to residual lesions.
海绵状血管瘤占儿童所有血管畸形的1.7%至18%,25%的病例见于18岁以下儿童。新生儿和婴儿期的病例已有报道,但平均年龄在9.1至10.2岁之间。男女之间无明显优势。
在儿童中,出血是常见表现,发生率在27.3%至78%之间,而成人患者为8%至37%。2.8%的患者出现孤立性头痛,20.1%观察到颅内压升高。癫痫在儿童中的报道发生率为16%至60%,具体取决于系列研究。22.7%的患者出现神经功能缺损,对于深部和脑干海绵状血管瘤,神经功能缺损更严重。约14.2%的病例在无症状患者中偶然发现。5%的病例观察到脊髓功能缺损。
结合文献数据及我们个人的57例病例系列,79.4%的病变位于幕上腔,20.6%位于后颅窝,大多数位于脑干,其中大部分在脑桥。脊髓海绵状血管瘤占所审查病例的5%,多发海绵状血管瘤占12.6%。
海绵状血管瘤的恰当治疗长期以来一直是诸多争论的主题。如今,已达成共识,无论病变位于何处,对于无症状和非出血性病变倾向于保守治疗,对于有症状和/或出血性海绵状血管瘤则倾向于手术治疗。神经影像学、手术定位、术中监测和显微外科技术的进展极大地促进了对这些病变的治疗方法改进。
回顾了217例病例的治疗结果。近70%的儿童神经功能完好,19.3%改善或稳定,2.7%恶化,1.13%死亡。癫痫的治疗结果非常令人鼓舞,除颞叶海绵状血管瘤外,手术在几乎所有儿童中都有效,对于颞叶海绵状血管瘤,建议进行侵入性术前评估。在大多数情况下,深部和脑干海绵状血管瘤可安全切除。仅有两名儿童因残留病变反复出血死亡。